Detalles de la búsqueda
1.
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(11): 1465-1477, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32961119
2.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
N Engl J Med
; 377(19): 1824-1835, 2017 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28891423
3.
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
N Engl J Med
; 375(19): 1845-1855, 2016 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717298
4.
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 18(3): 393-403, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28162999
5.
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 16(5): 522-30, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25840693
6.
Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma.
Cancer
; 119(9): 1675-82, 2013 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23400564
7.
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915).
J Clin Oncol
; 41(3): 517-527, 2023 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36162037
8.
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival.
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452930
9.
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials.
Cancer Immun
; 10: 9, 2010 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20957980
10.
Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study.
J Dermatol
; 46(12): 1197-1201, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31638282
11.
Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial.
Eur J Cancer
; 119: 1-10, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31400634
12.
Coadministration of muraglitazar plus glyburide: improvement of glycaemic and lipid profiles in patients with type 2 diabetes.
Diab Vasc Dis Res
; 6(2): 120-32, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20368202
Resultados
1 -
12
de 12
1
Próxima >
>>